LeonaBio, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that LeonaBio, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($6.61M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($6.97M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($6.97M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($9.14M) | May 9, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($9.14M) | Aug 7, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($9.14M) | Nov 6, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($28.74M) | Nov 6, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($26.86M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($26.86M) | Aug 7, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($26.34M) | Nov 6, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($26.34M) | May 9, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($26.34M) | Aug 7, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($32.97M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($29.60M) | Aug 1, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($29.60M) | Nov 7, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($27.82M) | May 15, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($27.82M) | Aug 1, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($27.82M) | Nov 7, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($20.19M) | Nov 9, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($24.34M) | Nov 9, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($6.87M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($7.29M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($9.54M) | May 9, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($29.62M) | Nov 6, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($28.03M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($27.69M) | May 9, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($35.04M) | Nov 7, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($31.64M) | Aug 1, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($29.77M) | May 15, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($24.13M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($23.57M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($23.39M) | May 11, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($17.83M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($16.64M) | Aug 15, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($10.78M) | May 12, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($7.40M) | Nov 10, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($2.25M) | Aug 16, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($1.27M) | May 13, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($1.54M) | Nov 12, 2020 |